To cite this paper use one of the standards below:
Sanguinarine is an alkaloid able to inhibit Bcl-xL, a protein which arrests cell death by apoptosis and is commonly overexpressed in tumor cells. Regarding to identify potential anticancer agents, two series of analogues from sanguinarine designed by molecular simplification were synthesized, and evaluated about their cytotoxic activity against U87 glioblastoma cells. Ten N-naphthyl-benzyl-amines and ten aryl-isoquinolines were synthesized and characterized by NMR 1H and 13C, HPLC and melting point. The most promising compound, the N-naphthyl-benzyl-amine derivative 4a, was, approximately, ten times more potent than the gold standard, temozolomide. This analogue induced cell cycle arrest at the G2/M phase, suggesting that it is a specific cell cycle compound. 4a further will be evaluated about its cell death mechanism and molecular docking will be performed in order to propose molecular interactions between the analogues and Bcl-xL. Our findings suggest that sanguinarine analogues may be a promising scaffold for designing antitumor agents.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper